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Policy & practice

Use of evidence to support healthy public policy: a policy
effectiveness–feasibility loop
Sarah Bowman,a Nigel Unwin,b Julia Critchley,c Simon Capewell,d Abdullatif Husseini,e Wasim Maziak,f
Shahaduz Zaman,a Habiba Ben Romdhane,g Fouad Fouad,h Peter Phillimore,a Belgin Unal,i Rana Khatib,j
Azza Shoaibij & Balsam Ahmada
Abstract Public policy plays a key role in improving population health and in the control of diseases, including non-communicable diseases.
However, an evidence-based approach to formulating healthy public policy has been difficult to implement, partly on account of barriers
that hinder integrated work between researchers and policy-makers. This paper describes a “policy effectiveness–feasibility loop” (PEFL) that
brings together epidemiological modelling, local situation analysis and option appraisal to foster collaboration between researchers and
policy-makers. Epidemiological modelling explores the determinants of trends in disease and the potential health benefits of modifying
them. Situation analysis investigates the current conceptualization of policy, the level of policy awareness and commitment among key
stakeholders, and what actually happens in practice, thereby helping to identify policy gaps. Option appraisal integrates epidemiological
modelling and situation analysis to investigate the feasibility, costs and likely health benefits of various policy options. The authors illustrate
how PEFL was used in a project to inform public policy for the prevention of cardiovascular diseases and diabetes in four parts of the eastern
Mediterranean. They conclude that PEFL may offer a useful framework for researchers and policy-makers to successfully work together to
generate evidence-based policy, and they encourage further evaluation of this approach.

Healthy public policy and its potential
Public policies, defined here as policies formulated at any
level of government,1 have been key in bringing about some
of the great public health achievements of the 19th and 20th
centuries, including clean water and sanitation, immunization, safe working conditions and fluoridation of water. 2
These examples represent “healthy public policies”, that is,
public policies that have or are intended to have a positive
impact on population health. Thus, public policies provide
one of the primary means for a society to organize its efforts
to protect and improve population health.3 It is increasingly
recognized that public policy can also play a key role in
the prevention and control of chronic, non-communicable
diseases (NCDs). Indeed, the United Nations High-Level
Meeting on Non-Communicable Diseases strongly emphasized the need for population-wide interventions involving
education, legislation and regulatory and fiscal measures.4
Public policy measures are likely to be as important in promoting healthier diets and physical activity as they have been
in reducing exposure to tobacco. However, the evidence on
which public policies are effective in promoting healthier
diets and physical activity is much scantier than the evidence
surrounding tobacco control policies, some of which are
known to be highly effective.5,6

Healthy public policy should be directed by evidence.7,8
However, an evidence-based approach to formulating healthy
public policy has proved difficult to develop and implement.9
Evidence is required in three broad areas: policy content,
policy implementation (i.e. translating content into effective
policy) and policy outcomes (i.e. achievement of the desired
effect).9 The aim of this paper is to present a framework designed to facilitate the development and implementation of
evidence-based healthy public policy for the prevention and
control of NCDs. The framework, known as the “policy effectiveness–feasibility loop” (PEFL), combines epidemiological
modelling, local situation analysis and policy option appraisal
and is designed to explicitly involve policy-makers. Below
we describe the PEFL framework and its application within a
project in four parts of the eastern Mediterranean.

Policy-making and research
In developing the PEFL framework, we were guided by the
literature on the factors that influence public policy development and on ways of encouraging the use of research evidence
to formulate healthy public policy (Box 1). The framework
highlights the importance of the “interface” between researchers
and policy-makers, particularly of promoting personal contact
and dialogue between them. Policy-makers need to receive
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clear, persuasive information on disease
burden and on interventions designed
to mitigate the burden. Offering policymakers choice and flexibility, such as a series of policy options with different costs
and benefits, is more likely to result in
action than providing them with a single
solution. It is important that the options
reflect the political, social and economic
realities within which a given policy will
be implemented. Finally, ongoing policy
surveillance and outcomes assessment
should be conducted to guide future
policy development and implementation.

The PEFL framework
The PEFL framework has three main
components: epidemiological modelling, situation analysis and option appraisal (Fig. 1). The epidemiological
modelling and situation analysis components are conducted simultaneously,
and the results of both are then integrated at the option appraisal stage. The
framework is designed to foster dialogue
and collaboration between researchers
and policy-makers, especially during
situation analysis and option appraisal.
During the former, policy-makers act
as participants who provide data and
insights on a particular situation; in the
latter, policy-makers play the key role,
which consists of identifying the options
that should be worked up in detail and
subsequently implemented.
Each component of the PEFL
framework is briefly described below. A
critical description of its application in
four parts of the eastern Mediterranean
follows for illustrative purposes.

Epidemiological modelling
In considering policy options for the
prevention of chronic NCDs, a natural
starting point is to try to understand
their epidemiological distribution and,
in particular, what drives trends in their
incidence and mortality over time. The
aim of the epidemiological modelling is
to gain this understanding. The resulting model can then be used to explore
the potential impact on incidence and
mortality of different policy options
intended to modify their determinants.
Our approach to epidemiological
modelling is based on the coronary
heart disease (CHD) IMPACT model,
with the addition of a “new” diabetes
policy model. 13 The CHD IMPACT
model, designed to estimate the relative
contribution of changes in risk factors
848

Box 1. Elements encouraging the use of research evidence in health policy, as addressed
in the policy effectiveness–feasibility loop framework
• Demonstrate public health burden and benefit or harm from an intervention9
• Use analytical tools and prepare and communicate data effectively, simply and persuasively.9
Summarize with clear recommendations;8 personalized through a story9
• Promote personal contact between researchers and policy-makers7,9 e.g. through networks
and “intermediary groups” (e.g. the media)10
• Invest in providing accessible, timely and relevant research for policy-makers3,11,12
• Clear political leadership, coordination and guidance7
• Estimate intervention cost9
• Consider “interface issues” when setting priorities, commissioning research and communicating
findings7
• Conduct policy surveillance and track outcomes with different types of evidence9
• Provide policy-makers with costed incremental policy options, enabling a stepwise approach
to policy implementation9

Fig. 1. The policy effectiveness–feasibility loop

Trends in burden of disease and risk factors

Evaluation of
interventions

Situation analysis:
stated and real policy,
health coverage, beliefs,
experience and opportunities

Epidemiology modelling: to
‘‘explain’’ incidence/mortality based
on risk factor trends, treatment
evidence, etc.

Option appraisal and selection:
intervention development,
feasibility, effectiveness and costs

and treatment coverage to trends in
mortality from CHD, has been successfully used in several high- and
middle-income countries. 14–16 The
model requires data on trends in CHD
mortality, major risk factors (e.g. smoking, arterial hypertension and diabetes)
and coverage of effective treatments for
the primary and secondary prevention
of CHD (e.g. thrombolytic therapy for
acute myocardial infarction and statins
for hypercholesterolaemia). Identifying
locally available data and assessing its
quality are therefore important initial
steps in the PEFL framework.

Situation analysis
The goal of the situation analysis is to
identify policy gaps as well as opportunities for implementing new policies
designed to improve health outcomes of
interest. Our approach to the situation

analysis has been developed over many
years. At first it built on rapid appraisal
methods 17,18 that were later adapted
and tested during the performance
of situation analyses of governmental
and health system responses to NCDs
in Africa, particularly Cameroon and
the United Republic of Tanzania.19 The
approach was further developed as part
of the project described in this paper.
The situation analysis is designed
to investigate existing policy and its
implementation at three levels (Fig. 2).
Level 1, or document analysis, involves
identifying, collating and systematically reviewing all relevant government
materials on health policies and health
services provision. Documents are identified with the help of policy-makers and
other local stakeholders and are reviewed
using standard proformas. This analysis
is conducted to gain an understanding
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of how the policy response is conceptualized (i.e. how it is meant to work in
theory). In Level 2, key informants are
interviewed to assess their awareness of
and adherence to the theory and to obtain
their insights into gaps and shortcomings within the system. Key informants
include policy-makers within ministries
of health as well as other important stakeholders. We developed semistructured
interview schedules for these interviews.
Finally, Level 3 involves investigating the
extent to which the policies are influencing practice. In our work this has entailed
direct participant observation (e.g.
observing the delivery of care in health
facilities) and individual interviews with
patients and family members. Triangulating the data from the three levels provides
a picture of policy as conceived theoretically versus actual practice and makes it
possible to identify opportunities for
implementing new policies and improving the implementation of existing ones.

Option appraisal and selection
Option appraisal and selection begins
once the results of the epidemiological
modelling and of the situation analysis
have been obtained. The modelling
identifies the major drivers of trends
in disease incidence and mortality and
enables “what if ” analyses to explore the
impact of policies intended to reduce risk
factor levels or increase the coverage of
health-care interventions. The situation
analysis provides insight into existing
policy gaps and the feasibility and acceptability (political, social and economic) of
different approaches to filling those gaps.
The results of the epidemiological
modelling and situation analysis are
used to generate a list of policy options.
Items on the list are then prioritized
with input from policy-makers and
other stakeholders, and some of the
options given higher priority are further
investigated by the research team, who
examine in detail their estimated costs,
potential health benefits and cost–effectiveness ratios. The options worked
up in this fashion are presented back to
the policy-makers, who then choose the
policies they wish to implement.

Using the PEFL framework
The PEFL framework was developed as
part of a multinational project known as
MedCHAMPS (MEDiterranean studies
of cardiovascular disease and hyperglycaemia: analytical modelling of popula-

Fig. 2. Situation analysis: overview of methods

Policy document review;
key informant
interviews (policy-makers
and others)

Conceptualization,
awareness
and commitment

Health-care worker and
patient interviews; illness
narratives; focus group
discussion and observation

Practice (including
health practice
and experience)

Barriers

tions’ socioeconomic transition).20 The
overall aim of the project was to inform
policy for the prevention and control of
cardiovascular diseases and diabetes in
four parts of the eastern Mediterranean:
the Syrian Arab Republic, Tunisia, Turkey and the West Bank and Gaza Strip.20
The project, which began in 2009, was
set up in a way intended to foster close
collaboration between researchers and
policy-makers. Its advisory committees, composed of policy-makers and
researchers established within each
study area at the start of the project, provided a forum for discussing the project’s
progress and results as these became
available. Seven senior policy-makers
attended many meetings throughout the
project. Although it would be premature
to comment on the long-term success of
the PEFL framework as applied in MedCHAMPS, which will not end until early
2013, some conclusions can be drawn
from the challenges faced and lessons
learnt while implementing this approach.

Epidemiological modelling
The main modelling activity undertaken
in MedCHAMPS was to build an IMPACT model in each of the four project
areas to explain trends in CHD mortality
over the past 10 to 15 years. The biggest
challenge was finding the data needed
to populate the epidemiological models. The first few months of the project
were spent in identifying available data
sources and appraising their quality and
completeness. Among the sources identified and used were routine mortality
statistics, national and local risk factor
surveys and statistics on health facility
activity and drug use. Nonetheless, a
shortage of data remained a major challenge and this was accounted for in the
model by making explicit assumptions
based on expert opinion and conducting
sensitivity analyses to test the effect of

Bull World Health Organ 2012;90:847–853 | doi:10.2471/BLT.12.104968

Gaps
Potential interventions
(locally appropriate and
judged as feasible)

Opportunities

changing the assumptions. The results
of the CHD modelling will be described
in detail in another paper, but here it is
worth noting that trends in age-adjusted
CHD mortality differ between project
areas. Mortality is increasing in Tunisia
and the Syrian Arab Republic but is
declining in Turkey and the West Bank
and Gaza Strip. The modelling was able
to show that these differences are partly
due to different trends in the prevalence
of smoking, mean blood pressure and
mean blood cholesterol levels. Despite
the shortage of data, however, the models were able to account for 75–100% of
the trends in CHD mortality and from
them it was possible to examine the
likely impact of interventions on future
epidemiological trends.
Because diabetes is a major, growing public health problem in the eastern Mediterranean, the need to model
trends in diabetes rates was identified. A
new diabetes model was built as part of
MedCHAMPS.13 The model is designed
to require minimum data while providing policy-makers with useful insights
into the potential impact of different
policy options on rates of diabetes and
its complications.

Situation analysis
Fig. 2 illustrates the three levels involved
in the situation analysis, as described
earlier. The biggest obstacles to achieving this ambitious design were the
relative novelty of and lack of familiarity
with qualitative research on the health
system in project areas. There were
differences between areas. Qualitative
health system research was most familiar
in Turkey and the West Bank and Gaza
Strip, where there is literature on the
organization of the health sector, and
it was least familiar in the Syrian Arab
Republic, where no such literature exists
and where critical scrutiny of a sector
849
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of government activity was inherently
problematic. These differences were important, moreover, because we needed
to obtain ethical consent and official
approval for similar timetables to gain
access to clinics and key informants
and perform the situation analyses in
all four settings simultaneously. We
were fortunate in that the standing of
our research partners in each study area
assured such access.
To examine “practice” we undertook direct observations in four clinics
in each study area. We purposively chose
the clinics to reflect different socioeconomic characteristics, both public and
private facilities and a mix of urban and
rural settings around the cities where
project partners were based (Ramallah,
Aleppo, Tunis and Izmir). At each clinic
we conducted structured interviews
with staff to investigate approaches and
challenges in caring for patients with
cardiovascular diseases and diabetes.
We also interviewed patients and family
members, also purposively chosen, to
explore their health beliefs and treatment experiences and identify any differences by age, sex or socioeconomic
status. The “practice” component of the
situation analysis is not intended to be
representative in an epidemiological
sense, but rather, to complement and
be triangulated with the information
gained from document reviews and key
informant interviews so as to highlight
recurring issues, problems or dilemmas.
We fortunately completed data collection for the situation analysis a few
months before the events that marked
the beginning of the “Arab awakening”
in Tunisia in December 2010. Therefore,
in two of the four project areas – the
Syrian Arab Republic and Tunisia – our
data reflect the situation that existed on
the cusp of the events that have been
unfolding since late 2010.

Option appraisal
As a starting point for the option appraisal, recommended and potentially
effective policy measures for the prevention and control of diabetes and cardiovascular diseases were considered. Two
frameworks were used for this purpose:
stepwise policy options for NCD prevention and control from the World Health
Organization21 and the framework for
public health interventions developed by
the United Kingdom’s National Institute
of Health and Clinical Excellence.22 In
the workshops, policy-makers and re850

searchers considered the recommended
options in light of the findings of the
epidemiological modelling and situation analyses. The following questions
were posed: (i) In light of the results of
the epidemiological modelling, what
interventions are particularly relevant
given the known burden of disease and
its determinants? (ii) In light of the
results of the situation analyses, what
interventions are likely to be acceptable
and feasible? A list of potential policy
options resulted from this exercise. To
further prioritize the items on the list,
policy-makers and other stakeholders
were asked to score each potential policy
option on a small set of criteria, including feasibility and likely public health
impact, in the same manner in which
WHO prioritizes the research agenda
for NCDs.23 All stakeholders complied
with the request.
The prioritized options underwent
further workup. This included cost
estimates, cost-effectiveness ratios and
a close look at their potential health
benefits and implementation requirements, such as resources needed, roles
and responsibilities involved and plans
for monitoring and evaluation. Using this
overall approach, five policy options were
worked up in detail for each study area.

Discussion
This paper presents a pragmatic framework for developing and prioritizing
policy interventions tailored to local
epidemiological, political and social
conditions. The PEFL framework was
developed as part of a multinational
project aiming to inform policy for
the prevention and control of cardiovascular diseases and diabetes in four
middle-income territories. Central to
the proposed approach is the iterative
involvement of policy-makers in the
collection of evidence and its appraisal.
The PEFL framework resembles the
“equity effectiveness loop” proposed by
Tugwell,24 which is intended to estimate
the impact of interventions to reduce
socioeconomic inequalities. The major
difference is that our approach includes
assessing the local context and the feasibility of potential interventions. Furthermore, our focus is on policy-level interventions, and hence the situation analysis
involves local policy-makers. The situation analysis and option appraisal stages
of our framework are analogous to policy
dialogue,25 as they facilitate discussion

between stakeholders and researchers
on policies and how to implement them.
The outputs resulting from application
of the framework can be used to prepare
policy briefs26 for informing stakeholder
discussions on policy options.
Studies have shown that evidence
rarely leads to policy changes directly.10
The relationship between evidence
and policy implementation has been
described as “complex, multifactorial,
nonlinear and highly context-specific”.11
Research evidence may be outweighed by
other factors, such as political pressure
from powerful interest groups. However,
the adoption of evidence-based policy
can be facilitated by involving policymakers in extended communication and
interaction with researchers9 and by using conceptual frameworks such as the
PEFL. Conceptual frameworks can also
be useful in assessing research utilization
and addressing the increasing demand
for accountability in research expenditure.8,27 Policy-makers and planners are
often enthusiastic about decision-support
frameworks, but these have seldom been
used in practice. Some policy-makers
may feel that frameworks oversimplify
complex situations or may not understand how frameworks operate work.12
Frameworks should be easy to understand and their assumptions should be
explicit, particularly when planning and
funding cycles are short and reorganization is frequent.27 The PEFL framework
is conceptually simple but does not oversimplify the epidemiological modelling,
situation analysis and option appraisal
components. Our approach is consistent
with the “interfaces and receptors” model
proposed by Hanney et al.8 insofar as it
aims to create interfaces between policymakers and researchers at various stages.
Explicitly involving policy-makers in the
epidemiological modelling stage is particularly valuable in promoting dialogue
between researchers and policy-makers
on what is currently known and where
further data are required
As shown in Box 2, one potential
limitation of the PEFL framework is
the methodological expertise required
to conduct the epidemiological modelling, the situation analysis and the
option appraisal. The MedCHAMPS
project has been building capacity in
these three areas within the project
areas. To facilitate the implementation
of the PEFL framework in other settings, researchers and policy-makers
should jointly investigate the valid-
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ity and utility of ways of conducting
epidemiological modelling, situation
analysis and option appraisals that
require fewer resources. In conclusion,
our early results show that implementing the PEFL framework within the
MedCHAMPS project has successfully enabled researchers and policymakers to work together on identifying
evidence-based, cost-effective and
feasible policy options for NCD prevention and control. ■
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ملخص

 حلقة فعالية السياسة – اجلدوى:استخدام البي ّنات لدعم السياسات العمومية الصحية

 مما سيساعد يف،املصلحة الرئيسيني وما حيدث بالفعل عند املامرسة
 ويؤدي تقييم اخليارات إىل التكامل بني.حتديد الثغرات السياسية
النمذجة الوبائية وحتليل األوضاع بغية حتري اجلدوى والتكاليف
 ويوضح.والفوائد الصحية املحتملة لشتى اخليارات السياسية
املؤلفون كيف تم استخدام “حلقة فعالية السياسة–اجلدوى” يف
أحد املشاريع إلبالغ السياسات العمومية لتوقي األمراض القلبية
 وخلصوا.الوعائية وداء السكري يف أربع مناطق يف رشق املتوسط
إىل أن “حلقة فعالية السياسة–اجلدوى” يمكن أن تقدم إطار ًا
مفيد ًا للباحثني وصناع السياسة إلنجاح التعاون بغية وضع سياسة
مستندة عىل البي ّنات وهم يشجعون إجراء املزيد من التقييم هلذا
.النهج

تلعب السياسة العمومية دور ًا رئيسي ًا يف حتسني صحة السكان ويف
 كان، ومع ذلك. بام فيها األمراض غري املعدية،مكافحة األمراض
من الصعب تنفيذ هنج مستند عىل البي ّنات الرامية لوضع سياسات
 وهو ما يعزى جزئي ًا إىل احلواجز التي تعيق العمل،عمومية صحية
 وتصف هذه الورقة.املتكامل بني الباحثني وصناع السياسة
) التي تقوم بتوحيدPEFL( ”“حلقة فعالية السياسة–اجلدوى
النمذجة الوبائية وحتليل األوضاع املحلية وتقييم اخليارات بغية
 وتستكشف النمذجة.دعم التعاون بني الباحثني وصناع السياسة
الوبائية حمددات االجتاهات يف املرض والفوائد الصحية املحتملة
 ويتحرى حتليل األوضاع التصميم احلايل للسياسات.من تعديلها
ومستوى الوعي وااللتزام عىل الصعيد السيايس بني أصحاب

摘要
使用证据支持健康的公共政策:政策的有效性-可行性循环
公共政策在改善人口的健康状况和控制疾病(包括非传染性
疾病)方面起着关键的作用。然而,采用以证据为基础制订的
健康公共政策的方法一直难以采用,这在一定程度上源于妨
碍研究人员和政策制定者之间的集成工作的障碍。本文介
绍了汇集流行病学建模、本地情况分析及选择方案评估以
促进研究人员和政策制定者之间合作的“政策有效性-可行
性循环”(PEFL)。流行病学建模探讨疾病发展趋势的决定
因素和改变这些因素的潜在健康益处。情况分析探讨了当
前政策的概念化、政策的认识水平、关键利益相关者之间

Bull World Health Organ 2012;90:847–853 | doi:10.2471/BLT.12.104968

的承诺和实践中的实际结果,从而帮助查明政策差距。选择
方案评估结合流行病学建模和情况分析,研究各种政策选择
的方案可行性、成本和可能的健康益处。作者举例说明在
一个项目中如何使用PEFL,为地中海东部四个区域旨在预
防心血管疾病和糖尿病制定的公共政策提供信息。他们
的结论是,PEFL可能为研究人员和政策制定者提供成功合
作的有用框架,以制定基于证据的政策,他们还鼓励进一步
评估这种方法。
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Résumé
Utilisation de preuves à l’appui d’une politique publique saine: la boucle entre efficacité et faisabilité d’une politique
La politique publique joue un rôle clé dans l’amélioration de la santé
de la population et dans la lutte contre les maladies, notamment les
maladies non transmissibles. Il a cependant été difficile de mettre
en œuvre une approche fondée sur des preuves pour formuler
une politique publique saine, en partie en raison des barrières qui
entravent le travail intégré entre chercheurs et décideurs. Cet article
décrit une «boucle entre efficacité et faisabilité d’une politique» (PEFL)
réunissant la modélisation épidémiologique, l’analyse de la situation
locale et l’évaluation des options afin de favoriser la collaboration entre
chercheurs et décideurs. La modélisation épidémiologique explore les
déterminants des évolutions de maladie et les avantages sanitaires
potentiels résultant de leur modification. L’analyse de situation étudie
la conceptualisation actuelle de la politique, le niveau de conscience

politique et l’engagement des principaux intervenants, et ce qui se
passe réellement dans la pratique, aidant ainsi à identifier les lacunes
de la politique. L’évaluation des options intègre la modélisation
épidémiologique et l’analyse de situation pour étudier la faisabilité, les
coûts et les avantages sanitaires potentiels de diverses options politiques.
Les auteurs montrent comment la PEFL a été utilisée dans un projet
visant à éclairer la politique publique sur la prévention des maladies
cardiovasculaires et du diabète dans quatre régions de la Méditerranée
orientale. Ils concluent que la PEFL peut offrir un cadre utile, permettant
aux chercheurs et aux décideurs de réussir à travailler ensemble pour
créer une politique basée sur des preuves, et ils encouragent une
évaluation plus approfondie de cette approche.

Резюме
Использование доказательств в поддержку здоровой государственной политики: цикл эффективностиосуществимости политики
Общественная политика играет ключевую роль в улучшении
здоровья населения и регулировании заболеваний, включая
неинфекционные заболевания. Тем не менее, реализация
доказательного подхода к формулированию здоровой
государственной политики представляется затруднительной,
отчасти из-за барьеров, препятствующих совместной работе
исследователей и представителей политических структур. В этом
докладе описывается «цикл эффективности-осуществимости
политики» (ЦЭОП), объединяющий эпидемиологическое
моделирование, локальный ситуационный анализ и вариантную
оценку для активизации совместной работы исследователей и
представителей политических структур. Эпидемиологическое
моделирование исследует определяющие факторы тенденций
заболевания, а также потенциальную пользу для здоровья
от их преобразования. Ситуационный анализ изучает
текущее концептуальное представление политики, уровень

информированности и приверженность политике ключевых
заинтересованных сторон, а также то, что в действительности
происходит на практике, таким образом, содействуя выявлению
недостатков политики. Вариантная оценка объединяет
эпидемиологическое моделирование и ситуационный анализ для
исследования обоснованности, затрат и вероятной пользы для
здоровья различных вариантов политики. Авторы иллюстрируют,
как ЦЭОП использовался в проекте по информированию
государственных служб о предотвращении сердечно-сосудистых
заболеваний и сахарного диабета в четырех регионах восточного
Средиземноморья. Они делают вывод, что ЦЭОП может стать
эффективной основой для ведения успешной совместной
работы исследователей и представителей политических структур
для выработки политики, основанной на доказательствах, и
призывают к дальнейшей оценке этого подхода.

Resumen
El uso de datos probatorios para reforzar la política sanitaria pública: una política de circuito cerrado eficacia-viabilidad
Las políticas públicas desempeñan un papel fundamental en la mejora
de la salud de la población y el control de enfermedades, incluidas las
enfermedades no transmisibles. Sin embargo, ha sido difícil implementar
un enfoque basado en datos probatorios para formular una política
sanitaria pública, debido en parte a los obstáculos que impiden el trabajo
integrado entre investigadores y legisladores. El presente documento
describe una política de circuito cerrado eficacia-viabilidad (PEFL,
por sus siglas en inglés) que reúne la modelización epidemiológica,
el análisis de la situación local y la valoración de las opciones para
promover la colaboración entre investigadores y legisladores. El modelo
epidemiológico examina los factores determinantes de las tendencias
de una enfermedad y los beneficios sanitarios posibles resultantes de
una modificación de los mismos. El análisis de la situación investiga
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la conceptualización actual de la política, el nivel de conciencia y
compromiso con esa política entre las partes clave interesadas y lo que
sucede en la práctica, ayudando, por tanto, a identificar las lagunas en la
política. La valoración de las opciones integra el modelo epidemiológico
y el análisis de la situación para averiguar la viabilidad, los costes
y los beneficios sanitarios posibles de varias políticas posibles. Los
autores ilustran cómo se empleó el PEFL en un proyecto para informar
acerca de una política pública para la prevención de enfermedades
cardiovasculares y diabetes en cuatro áreas del Mediterráneo Oriental.
Concluyen que el PEFL puede ofrecer un marco útil a los investigadores
y legisladores para trabajar con éxito juntos con objeto de crear una
política basada en datos probatorios, y animan a seguir evaluando
dicho enfoque.
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